Anticancer Effects of Green Tea and the Underlying Molecular Mechanisms in Bladder Cancer

por Miyata, Yasuyoshi, Matsuo, Tomohiro, Araki, Kyohei, Nakamura, Yuichiro, Sagara, Yuji, Ohba, Kojiro, Sakai, Hideki
Publicado 2018

Oral Intake of Royal Jelly Has Protective Effects Against Tyrosine Kinase Inhibitor-Induced Toxicity in Patients with Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Co...

por Araki, Kyohei, Miyata, Yasuyoshi, Ohba, Kojiro, Nakamura, Yuichiro, Matsuo, Tomohiro, Mochizuki, Yasushi, Sakai, Hideki
Publicado 2018

Efficacy of Tadalafil Therapy and Changes in Oxidative Stress Levels in Male Patients with Lower Urinary Tract Symptoms and Overactive Bladder

por Matsuo, Tomohiro, Miyata, Yasuyoshi, Araki, Kyohei, Mukae, Yuta, Otsubo, Asato, Ohba, Kojiro, Sakai, Hideki
Publicado 2019

Correction: Oral Intake of Royal Jelly Has Protective Effects against Tyrosine Kinase Inhibitor-Induced Toxicity in Patients with Renal Cell Carcinoma: A Randomized, Double-Blinded...

por Araki, Kyohei, Miyata, Yasuyoshi, Ohba, Kojiro, Nakamura, Yuichiro, Matsuo, Tomohiro, Mochizuki, Yasushi, Sakai, Hideki
Publicado 2020

Pathological roles of c-Met in bladder cancer: Association with cyclooxygenase-2, heme oxygenase-1, vascular endothelial growth factor-A and programmed death ligand 1

por Mukae, Yuta, Miyata, Yasuyoshi, Nakamura, Yuichiro, Araki, Kyohei, Otsubo, Asato, Yuno, Tsutomu, Mitsunari, Kensuke, Matsuo, Tomohiro, Ohba, Kojiro, Sakai, Hideki
Publicado 2020

Oral intake of royal jelly improves anti-cancer effects and suppresses adverse events of molecular targeted therapy by regulating TNF-α and TGF-β in renal cell carcinoma: A prelimi...

por Miyata, Yasuyoshi, Araki, Kyohei, Ohba, Kojiro, Mastuo, Tomhiro, Nakamura, Yuichiro, Yuno, Tsutomu, Mukai, Yuta, Otsubo, Asato, Mitsunari, Kensuke, Mochizuki, Yasushi, Sakai, Hideki
Publicado 2020

Oral intake of royal jelly improves anti-cancer effects and suppresses adverse events of molecular targeted therapy by regulating TNF-α and TGF-β in renal cell carcinoma: A prelimi...

por Miyata, Yasuyoshi, Araki, Kyohei, Ohba, Kojiro, Mastuo, Tomhiro, Nakamura, Yuichiro, Yuno, Tsutomu, Mukai, Yuta, Otsubo, Asato, Mitsunari, Kensuke, Mochizuki, Yasushi, Sakai, Hideki
Publicado 2020

Oral administration of E-type prostanoid (EP) 1 receptor antagonist suppresses carcinogenesis and development of prostate cancer via upregulation of apoptosis in an animal model

por Masato, Masahito, Miyata, Yasuyoshi, Kurata, Hiroki, Ito, Hidenori, Mitsunari, Kensuke, Asai, Akihiro, Nakamura, Yuichiro, Araki, Kyohei, Mukae, Yuta, Matsuda, Tsuyoshi, Harada, Junki, Matsuo, Tomohiro, Ohba, Kojiro, Sakai, Hideki
Publicado 2021